One crucial issue in the design of the dual-targeted complex presented in this study, aimed at the targeting of the mitochondria of GRPr-positive prostate cancer cells, was the presence of a triglycine linker between the BBN peptide and the organometallic fragment carrying the mitotropic group. The gene discussed is GRPR; the disease is prostate carcinoma.